34 min

Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In‪?‬ Keeping Current CME

    • Medicine

Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000707?ecd=bdc_podcast_libsyn_mscpedu

Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000707?ecd=bdc_podcast_libsyn_mscpedu

34 min

More by Medscape

This Week in Cardiology
This Week in Cardiology
Medscape
Medicine and the Machine
Medicine and the Machine
Medscape
Keeping Current
Keeping Current
Medscape Podcasts
Keeping Current CME
Keeping Current CME
Medscape
One-on-One with Eric Topol
One-on-One with Eric Topol
Medscape
The Bob Harrington Show
The Bob Harrington Show
Medscape